Proteasome
The proteasome is a large multisubunit complex of approximately 2.5 MDa that mediates a wide range of physiological and pathological cellular processes by selectively degrading unnecessary proteins in eukaryotes. The structure of a proteasome is comprised of the catalytic core particle (CP) and two terminal regulatory particles (RPs). The CP (also known as the 20S proteasome) is a barrel shaped multisubunit complex (approximately 750 kDa) consisting of four axially stacked heptameric rings (two outer α-rings and two inner β-rings) with 7 subunits in each ring, where three β subunits (β1, β2 and β5) contain catalytically active threonine residues and are associated with caspase-like, trypsin-like and chymotrypsin-like activities respectively.
Products for Proteasome
- Cat.No. Product Name Information
-
BCN5973
Artemether
-
BCN5986
Celastrol Topoisomerase II inhibitor
-
BCN3894
Gliotoxin Inhibitor of 20S proteasome; immunosuppressant
-
BCN1841
Lactacystin Cell-permeable, potent and selective proteasome inhibitor
-
BCC1124
PSIProteasome inhibitor
-
BCC1145
Carfilzomib (PR-171)Proteasome inhibitor,epoxomicin analog
-
BCC1146
Oprozomib (ONX-0912)Proteasome inhibitor
-
BCC1224
Clasto-Lactacystin β-lactoneProteasome inhibitor
-
BCC1227
MG-132Calpain and proteasome inhibitor
-
BCC1232
Aclacinomycin ATopoisomerase I and II inhibitor
-
BCC1235
EpoxomicinProteasome inhibitor
-
BCC1237
MG-115Potent reversible proteasome inhibitor
-
BCC1238
Bortezomib (PS-341)Proteasome Inhibitor
-
BCC2091
MLN9708Proteasome inhibitor
-
BCC2092
MLN2238β5 site of the 20S proteasome inhibitor
-
BCC2093
CEP-18770Proteasome inhibitor
-
BCC2094
Salinosporamide A (NPI-0052, Marizomib)20S proteasome inhibitor
-
BCC2095
ONX-0914 (PR-957)Immunoproteasome inhibitor,potent and selective
-
BCC2097
Aspirin (Acetylsalicylic acid)Cyclooxygenase inhibitor; NSAID
-
BCC3589
AM 11420S proteasome inhibitor
-
BCC3596
DihydroeponemycinProteasome inhibitor,antitumor reagent,eponemycin ddrivative